Has Kinim Smith, MD received payments from drug or device companies?

Yes. Drug and device makers reported $5,712 in general payments to Kinim Smith, MD across 256 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kinim Smith, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kinim Smith, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kinim Smith, MD

Rheumatology · Hannibal, MONPI 1275646473

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.8% of the total across 256 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 18.5% — the pattern of someone who eats at a lot of different presentations.

$5,712in general payments, 2019–2025

Across 256 payments — averaging $22.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

UCB, Inc.$1K
AbbVie$901
AstraZeneca$643
Amgen$560
Johnson & Johnson$497
GSK$323
plus $2K from 17 others

What the payments were for

Grants$2404%
Food & beverage$5,35994%
Education$1132%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
UCB, Inc.	60	$1,056
AbbVie	37	$901
AstraZeneca(2 entities)	22	$643
Amgen(2 entities)	31	$560
Johnson & Johnson	21	$497
GSK	6	$323
Novartis	11	$291
E.r. Squibb & Sons, L.L.C.	15	$248
Genentech USA, Inc.	9	$219
Lilly USA, LLC	9	$175
Kyowa Kirin, Inc.	2	$142
ANI Pharmaceuticals, Inc.	6	$128
Boehringer Ingelheim	6	$105
Pfizer	4	$72
Sandoz	3	$70
Organon	3	$64
Mallinckrodt Hospital Products Inc.	3	$60
Mallinckrodt Enterprises LLC	2	$42
Collegium Pharmaceutical, Inc.	2	$39
Vertex	1	$21
Aurinia Pharma U.S., Inc.	1	$21
Fidia Pharma USA Inc.	1	$19
Shionogi Inc	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Rinvoq$240
SAPHNELO$225
CRYSVITA$121
Bimzelx$118
Tremfya$110

How this compares

$5,712 in reported general payments places this provider in the 70th percentile of 134 rheumatology providers in Missouri.

See all rheumatology providers in Missouri →

Medicare billing

Part B allowed, 2024

$536,804

Medicare patients

Services billed

74,157

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
MethotrexateMethotrexate Sodium	179	$4,905
Mycophenolate Mofetil	18	$4,580
Hydroxychloroquine Sulfate	55	$2,946
Leflunomide	61	$2,635
Fentanyl	26	$2,524
Methadone Hcl	72	$1,953
Oxycodone Hcl	94	$1,815
Azathioprine	35	$1,696
Morphine Sulfate ErMorphine Sulfate	15	$1,390
Celecoxib	25	$1,009
Misoprostol	12	$1,004
Tramadol Hcl	58	$932
Sulindac	31	$601
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	25	$569
Morphine Sulfate	12	$567

Paid to pharmacies, not to this prescriber.

Other rheumatology in Hannibal

Anne WinklerCarthage$1.6M
Adam KilianSaint Louis$565K
Alfred KimSaint Louis$486K
Mark BoxKansas City$304K
Sona KamatSaint Louis$268K
Robert JacksonMemphis$152K
Richard BrasingtonSaint Louis$100K
Michael JosephJoplin$94K
Ghaith NoaisehKansas City$69K
Thomas ScottKansas City$48K

See the full list for Missouri →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →